Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
Completed · Phase 2 · Has a placebo group
Conditions studied: Asthma
In brief
This study assessed the effect on asthma control of different dose levels and regimens of QGE031 in asthma patients that are inadequately controlled with inhaled steroid and beta-2 agonist medication. Safety was assessed also. Comparison was to placebo and omalizumab. Information from this study was planned to support the design of future studies.
Key facts
- Study ID
- NCT01716754
- Run by
- Novartis Pharmaceuticals
- People needed
- 471
- Starts
- 2012-12-01
- Expected to finish
- 2016-01-01
- Last updated by the study team
- 2017-08-11
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Hawaiian Gardens, California, United States
- Novartis Investigative Site — Riverside, California, United States
- Novartis Investigative Site — San Jose, California, United States
- Novartis Investigative Site — Vista, California, United States
- Novartis Investigative Site — Evansville, Indiana, United States
- Novartis Investigative Site — Owensboro, Kentucky, United States
- Novartis Investigative Site — Columbia, Maryland, United States
- Novartis Investigative Site — Waldorf, Maryland, United States
- Novartis Investigative Site — Novi, Michigan, United States
- Novartis Investigative Site — Minneapolis, Minnesota, United States
- Novartis Investigative Site — Omaha, Nebraska, United States
- Novartis Investigative Site — Papillion, Nebraska, United States
- Novartis Investigative Site — Brooklyn, New York, United States
- Novartis Investigative Site — Mineola, New York, United States
- Novartis Investigative Site — Cincinnati, Ohio, United States
- Novartis Investigative Site — Lincoln, Rhode Island, United States
- Novartis Investigative Site — Mt. Pleasant, South Carolina, United States
- Novartis Investigative Site — Summerville, South Carolina, United States
- Novartis Investigative Site — Salt Lake City, Utah, United States
- Novartis Investigative Site — Fairfax, Virginia, United States
- Novartis Investigative Site — Everett, Washington, United States
- Novartis Investigative Site — CABA, Buenos Aires, Argentina
- Novartis Investigative Site — CABA, Buenos Aires, Argentina
- Novartis Investigative Site — Mar del Plata, Buenos Aires, Argentina
- Novartis Investigative Site — Fresno, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.